Company Filing History:
Years Active: 2019-2023
Title: Innovations by Inventor Xiaojun Lei in Molecular Diagnostics
Introduction
Xiaojun Lei is a prominent inventor based in San Jose, CA, known for his contributions to the field of molecular diagnostics. With a portfolio that includes two patents, Lei has developed innovative technologies that advance the accuracy and efficiency of diagnostic processes.
Latest Patents
Lei's latest patents include a groundbreaking assay cartridge for molecular diagnosis. This patent details an assay cartridge designed for use in PCR-based molecular diagnostic devices. The cartridge features an elongated body with multiple compartments, including pipette tip holders at both ends, and is equipped with a seal assembly comprising a rigid frame and an elastic top to ensure precision during testing.
Additionally, he has developed systems and methods for molecular diagnostics, focusing on the processing and analysis of samples. This system incorporates assay cartridges with sample preparation modules, PCR modules, thermal cycler modules, and optics modules to accurately detect specific nucleic acid sequences in various samples.
Career Highlights
Xiaojun Lei is an integral part of Quandx Inc., a company recognized for its innovations in molecular diagnostics. His work has been pivotal in creating tools that enhance the diagnostic capabilities of healthcare professionals, facilitating more reliable and timely results for patients.
Collaborations
Throughout his career, Lei has collaborated with fellow inventors and researchers, including notable coworkers Qian Xu and Yuan Yuan. Together, they have contributed to advancements in diagnostic technologies, showcasing the value of teamwork and shared expertise in the field.
Conclusion
Inventor Xiaojun Lei continues to make significant strides in molecular diagnostics through his patents and collaborative efforts. His innovative designs and systems reflect a commitment to enhancing healthcare through technology, ultimately benefiting both medical providers and patients alike.